Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

450 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cross-sectional estimates revealed high HIV incidence in Botswana rural communities in the era of successful ART scale-up in 2013-2015.
Moyo S, Gaseitsiwe S, Mohammed T, Pretorius Holme M, Wang R, Kotokwe KP, Boleo C, Mupfumi L, Yankinda EK, Chakalisa U, van Widenfelt E, Gaolathe T, Mmalane MO, Dryden-Peterson S, Mine M, Lebelonyane R, Bennett K, Leidner J, Wirth KE, Tchetgen Tchetgen E, Powis K, Moore J, Clarke WA, Lockman S, Makhema JM, Essex M, Novitsky V. Moyo S, et al. PLoS One. 2018 Oct 24;13(10):e0204840. doi: 10.1371/journal.pone.0204840. eCollection 2018. PLoS One. 2018. PMID: 30356287 Free PMC article. Clinical Trial.
The reverse transcriptase 67N 70R 215Y genotype is the predominant TAM pathway associated with virologic failure among HIV type 1C-infected adults treated with ZDV/ddI-containing HAART in southern Africa.
Novitsky V, Wester CW, DeGruttola V, Bussmann H, Gaseitsiwe S, Thomas A, Moyo S, Musonda R, Van Widenfelt E, Marlink RG, Essex M. Novitsky V, et al. Among authors: moyo s. AIDS Res Hum Retroviruses. 2007 Jul;23(7):868-78. doi: 10.1089/aid.2006.0298. AIDS Res Hum Retroviruses. 2007. PMID: 17678469
Higher-than-expected rates of lactic acidosis among highly active antiretroviral therapy-treated women in Botswana: preliminary results from a large randomized clinical trial.
Wester CW, Okezie OA, Thomas AM, Bussmann H, Moyo S, Muzenda T, Makhema J, van Widenfelt E, Musonda R, Novitsky V, Gaolathe T, Ndwapi N, Essex M, Kuritzkes DR, DeGruttola V, Marlink RG. Wester CW, et al. Among authors: moyo s. J Acquir Immune Defic Syndr. 2007 Nov 1;46(3):318-22. doi: 10.1097/QAI.0b013e3181568e3f. J Acquir Immune Defic Syndr. 2007. PMID: 18090299 Clinical Trial.
Evolution of proviral gp120 over the first year of HIV-1 subtype C infection.
Novitsky V, Lagakos S, Herzig M, Bonney C, Kebaabetswe L, Rossenkhan R, Nkwe D, Margolin L, Musonda R, Moyo S, Woldegabriel E, van Widenfelt E, Makhema J, Essex M. Novitsky V, et al. Among authors: moyo s. Virology. 2009 Jan 5;383(1):47-59. doi: 10.1016/j.virol.2008.09.017. Epub 2008 Oct 29. Virology. 2009. PMID: 18973914 Free PMC article.
Response to zidovudine/didanosine-containing combination antiretroviral therapy among HIV-1 subtype C-infected adults in Botswana: two-year outcomes from a randomized clinical trial.
Bussmann H, Wester CW, Thomas A, Novitsky V, Okezie R, Muzenda T, Gaolathe T, Ndwapi N, Mawoko N, Widenfelt E, Moyo S, Musonda R, Mine M, Makhema J, Moffat H, Essex M, Degruttola V, Marlink RG. Bussmann H, et al. Among authors: moyo s. J Acquir Immune Defic Syndr. 2009 May 1;51(1):37-46. doi: 10.1097/QAI.0b013e31819ff102. J Acquir Immune Defic Syndr. 2009. PMID: 19282782 Free PMC article. Clinical Trial.
Viral load and CD4+ T-cell dynamics in primary HIV-1 subtype C infection.
Novitsky V, Woldegabriel E, Kebaabetswe L, Rossenkhan R, Mlotshwa B, Bonney C, Finucane M, Musonda R, Moyo S, Wester C, van Widenfelt E, Makhema J, Lagakos S, Essex M. Novitsky V, et al. Among authors: moyo s. J Acquir Immune Defic Syndr. 2009 Jan 1;50(1):65-76. doi: 10.1097/QAI.0b013e3181900141. J Acquir Immune Defic Syndr. 2009. PMID: 19295336 Free PMC article.
Quantitation of human immunodeficiency virus type 1 viral load in plasma using reverse transcriptase activity assay at a district hospital laboratory in Botswana: a decentralization pilot study.
Mine M, Bedi K, Maruta T, Madziva D, Tau M, Zana T, Gaolathe T, Moyo S, Seipone K, Ndwapi N, Essex M, Marlink R. Mine M, et al. Among authors: moyo s. J Virol Methods. 2009 Jul;159(1):93-7. doi: 10.1016/j.jviromet.2009.03.008. Epub 2009 Mar 20. J Virol Methods. 2009. PMID: 19442851
Better control of early viral replication is associated with slower rate of elicited antiviral antibodies in the detuned enzyme immunoassay during primary HIV-1C infection.
Novitsky V, Wang R, Kebaabetswe L, Greenwald J, Rossenkhan R, Moyo S, Musonda R, Woldegabriel E, Lagakos S, Essex M. Novitsky V, et al. Among authors: moyo s. J Acquir Immune Defic Syndr. 2009 Oct 1;52(2):265-72. doi: 10.1097/QAI.0b013e3181ab6ef0. J Acquir Immune Defic Syndr. 2009. PMID: 19525854 Free PMC article.
Timing constraints of in vivo gag mutations during primary HIV-1 subtype C infection.
Novitsky V, Wang R, Margolin L, Baca J, Kebaabetswe L, Rossenkhan R, Bonney C, Herzig M, Nkwe D, Moyo S, Musonda R, Woldegabriel E, van Widenfelt E, Makhema J, Lagakos S, Essex M. Novitsky V, et al. Among authors: moyo s. PLoS One. 2009 Nov 5;4(11):e7727. doi: 10.1371/journal.pone.0007727. PLoS One. 2009. PMID: 19890401 Free PMC article.
450 results